News

Vanderbilt

Encephalitis identified as rare toxicity of immunotherapy treatment

July 22, 2019

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center (VICC) investigated why the complication occurred, performing a molecular analysis of the disease’s pathology and mining data to determine…

Read More

This illustration shows the H. pylori bacterium and a close-up of its “injector” at the stomach lining.

Vanderbilt team shows how stomach bug can trigger cancer

July 11, 2019

Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining.

Read More